... reference prices for innovator brands and 11.41 times for the lowest-priced generics. Many drugs for diseases like HIV/AIDS, cancer, and hepatitis B and C are already too expensive for most people, Oxfam said. The TPP pact also comes at a bad time ...
http://www.thanhniennews.com/index/pages/20131122-vietnam-other-developing-nations-could-lose-as-us-seeks-largesse-for-big-pharma.aspx
http://www.thanhniennews.com/index/pages/20131122-vietnam-other-developing-nations-could-lose-as-us-seeks-largesse-for-big-pharma.aspx
No comments:
Post a Comment